{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:09:15Z","timestamp":1790226555728,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00066-025-02409-9","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T02:48:55Z","timestamp":1746499735000},"page":"160-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Survival determinants and toxicity of second-course radiotherapy for isolated nodal recurrences in breast cancer"],"prefix":"10.1007","volume":"202","author":[{"given":"Cezara","family":"Cheptea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Baude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Laki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fourquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-8110","authenticated-orcid":false,"given":"Pierre","family":"Loap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"issue":"9","key":"2409_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/archsurg.141.9.867","volume":"141","author":"DE Konkin","year":"2006","unstructured":"Konkin\u00a0DE, Tyldesley\u00a0S, Kennecke\u00a0H, Speers\u00a0CH, Olivotto\u00a0IA, Davis\u00a0N (2006) Management and outcomes of isolated axillary node recurrence in breast cancer. Arch Surg 141(9):867\u2013874","journal-title":"Arch Surg"},{"issue":"5","key":"2409_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar\u00a0WJ, Moran\u00a0MS, Abraham\u00a0J, Abramson\u00a0V, Aft\u00a0R, Agnese\u00a0D et\u00a0al (2024) Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J\u00a0Natl Compr Canc Netw 22(5):331\u2013357","journal-title":"J Natl Compr Canc Netw"},{"key":"2409_CR3","doi-asserted-by":"publisher","first-page":"103121","DOI":"10.1016\/j.critrevonc.2020.103121","volume":"156","author":"P Loap","year":"2020","unstructured":"Loap\u00a0P, Kirov\u00a0K, Kirova\u00a0Y (2020) Cardiotoxicity in breast cancer patients treated with radiation therapy: from evidences to controversies. Crit Rev Oncol Hematol 156:103121","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"2409_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1046\/j.1365-2168.2001.01637.x","volume":"88","author":"R de Boer","year":"2001","unstructured":"de Boer\u00a0R, Hillen\u00a0HFP, Roumen\u00a0RMH, Rutten\u00a0HJT, van der Sangen\u00a0MJC, Voogd\u00a0AC (2001) Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer. Br J Surg 88(1):118\u2013122","journal-title":"Br J Surg"},{"issue":"4","key":"2409_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0002-9610(00)00456-6","volume":"180","author":"LA Newman","year":"2000","unstructured":"Newman\u00a0LA, Hunt\u00a0KK, Buchholz\u00a0T, Kuerer\u00a0HM, Vlastos\u00a0G, Mirza\u00a0N et\u00a0al (2000) Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg 180(4):252\u2013256","journal-title":"Am J Surg"},{"key":"2409_CR6","doi-asserted-by":"crossref","unstructured":"Loap P, Tkatchenko N, Goudjil F, Ribeiro M, Baron B, Fourquet A et\u00a0al (2021) Cardiac substructure exposure in breast radiotherapy: a\u00a0comparison between intensity modulated proton therapy and volumetric modulated arc therapy. Acta Oncol: 1\u20137","DOI":"10.1080\/0284186X.2021.1907860"},{"issue":"2","key":"2409_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/0284186X.2023.2177976","volume":"62","author":"P Loap","year":"2023","unstructured":"Loap\u00a0P, Vu-Bezin\u00a0J, Monceau\u00a0V, Jacob\u00a0S, Fourquet\u00a0A, Kirova\u00a0Y (2023) Dosimetric evaluation of the benefit of deep inspiration breath hold (DIBH) for locoregional irradiation of right breast cancer with volumetric modulated arctherapy (VMAT). Acta Oncol 62(2):150\u2013158","journal-title":"Acta Oncol"},{"key":"2409_CR8","doi-asserted-by":"crossref","unstructured":"Ga\u00e1l S, Kah\u00e1n Z, Paczona V, K\u00f3sz\u00f3 R, Drencs\u00e9nyi R, Szab\u00f3 J et\u00a0al (2021) Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility. Radiat Oncol (16):89","DOI":"10.1186\/s13014-021-01816-3"},{"key":"2409_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tipsro.2021.02.006","volume":"17","author":"S Ferdinand","year":"2021","unstructured":"Ferdinand\u00a0S, Mondal\u00a0M, Mallik\u00a0S, Goswami\u00a0J, Das\u00a0S, Manir\u00a0KS et\u00a0al (2021) Dosimetric analysis of deep inspiratory breath-hold technique (DIBH) in left-sided breast cancer radiotherapy and evaluation of pre-treatment predictors of cardiac doses for guiding patient selection for DIBH. Tech Innov Patient Support Radiat Oncol 17:25\u201331","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"issue":"3","key":"2409_CR10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.radonc.2013.10.038","volume":"110","author":"YM Kirova","year":"2014","unstructured":"Kirova\u00a0YM, Hijal\u00a0T, Campana\u00a0F, Fournier-Bidoz\u00a0N, Stilhart\u00a0A, Dendale\u00a0R et\u00a0al (2014) Whole breast radiotherapy in the lateral decubitus position: a\u00a0dosimetric and clinical solution to decrease the doses to the organs at risk (OAR). Radiother Oncol 110(3):477\u2013481","journal-title":"Radiother Oncol"},{"issue":"2","key":"2409_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.radonc.2017.07.001","volume":"124","author":"E Bronsart","year":"2017","unstructured":"Bronsart\u00a0E, Dureau\u00a0S, Xu\u00a0HP, Bazire\u00a0L, Chilles\u00a0A, Costa\u00a0E et\u00a0al (2017) Whole breast radiotherapy in the lateral isocentric lateral decubitus position: long-term efficacy and toxicity results. Radiother Oncol 124(2):214\u2013219","journal-title":"Radiother Oncol"},{"issue":"9","key":"2409_CR12","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid\u00a0P, Cortes\u00a0J, Pusztai\u00a0L, McArthur\u00a0H, K\u00fcmmel\u00a0S, Bergh\u00a0J et\u00a0al (2020) Pembrolizumab for early triple-negative breast cancer. N\u00a0Engl J Med 382(9):810\u2013821","journal-title":"N Engl J Med"},{"issue":"2","key":"2409_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/annonc\/mdr129","volume":"23","author":"E Montagna","year":"2012","unstructured":"Montagna\u00a0E, Bagnardi\u00a0V, Rotmensz\u00a0N, Viale\u00a0G, Renne\u00a0G, Cancello\u00a0G et\u00a0al (2012) Breast cancer subtypes and outcome after local and regional relapse. Ann Oncol 23(2):324\u2013331","journal-title":"Ann Oncol"},{"key":"2409_CR14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028485","author":"A Bardia","year":"2021","unstructured":"Bardia\u00a0A, Hurvitz\u00a0SA, Tolaney\u00a0SM, Loirat\u00a0D, Punie\u00a0K, Oliveira\u00a0M et\u00a0al (2021) Sacituzumab Govitecan in metastatic triple-negative breast cancer. N\u00a0Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2028485","journal-title":"N Engl J Med"},{"issue":"10","key":"2409_CR15","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1245\/s10434-022-12193-w","volume":"29","author":"M Pilewskie","year":"2022","unstructured":"Pilewskie\u00a0M, Sevilimedu\u00a0V, Eroglu\u00a0I, Le\u00a0T, Wang\u00a0R, Morrow\u00a0M et\u00a0al (2022) How often do sentinel lymph node biopsy results affect Adjuvant therapy decisions among postmenopausal women with early-stage HR+\/HER2\u2212 breast cancer in the post-RxPONDER era? Ann Surg Oncol 29(10):6267\u20136273","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"2409_CR16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1200\/JCO.2017.76.5719","volume":"36","author":"IL Wapnir","year":"2018","unstructured":"Wapnir\u00a0IL, Price\u00a0KN, Anderson\u00a0SJ, Robidoux\u00a0A, Mart\u00edn\u00a0M, Nortier\u00a0JWR et\u00a0al (2018) Efficacy of chemotherapy for ER-negative and ER-positive isolated Locoregional recurrence of breast cancer: final analysis of the CALOR trial. J\u00a0Clin Oncol 36(11):1073\u20131079","journal-title":"J Clin Oncol"},{"issue":"4","key":"2409_CR17","doi-asserted-by":"publisher","first-page":"OT-26-02","DOI":"10.1158\/1538-7445.SABCS20-OT-26-02","volume":"81","author":"E Munzone","year":"2021","unstructured":"Munzone\u00a0E, Aebi\u00a0S, Ja\u00f1ez\u00a0NM, G\u00fcth\u00a0U, Bellet\u00a0M, Pistilli\u00a0B et\u00a0al (2021) Abstract OT-26-02: phase\u00a0III open-label, multicenter, randomized trial of adjuvant palbociclib in combination with endocrine therapy versus endocrine therapy alone for patients with hormone receptor-positive \/ HER2\u2212negative resected isolated locoregional recurrence of breast cancer\u2014the POLAR trial. Cancer Res 81(4):OT-26-02","journal-title":"Cancer Res"},{"issue":"6","key":"2409_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41416-020-0957-9","volume":"123","author":"A Beddok","year":"2020","unstructured":"Beddok\u00a0A, Xu\u00a0HP, Henry\u00a0AA, Porte\u00a0B, Fourquet\u00a0A, Cottu\u00a0P et\u00a0al (2020) Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature. Br J Cancer 123(6):905\u2013908","journal-title":"Br J Cancer"},{"issue":"12","key":"2409_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/COC.0000000000001131","volume":"47","author":"J Bouziane","year":"2024","unstructured":"Bouziane\u00a0J, Loap\u00a0P, Cottu\u00a0P, Escalup\u00a0L, Kirova\u00a0Y (2024) Concurrent use of radiotherapy and Ribociclib: preliminary results and review of the literature. Am J Clin Oncol 47(12):574\u2013579","journal-title":"Am J Clin Oncol"},{"key":"2409_CR20","doi-asserted-by":"crossref","unstructured":"Tison T, Loap P, Arnaud E, Cao K, Bringer S, Kissel M et\u00a0al (2023) Tolerance of concurrent adjuvant radiotherapy and pembrolizumab for triple negative breast cancer: real life experience. Adv Radiat Oncol: 101384","DOI":"10.1016\/j.adro.2023.101384"},{"issue":"19","key":"2409_CR21","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.3390\/cancers13194790","volume":"13","author":"A Aboudaram","year":"2021","unstructured":"Aboudaram\u00a0A, Loap\u00a0P, Loirat\u00a0D, Dhia\u00a0SB, Cao\u00a0K, Fourquet\u00a0A et\u00a0al (2021) Pertuzumab and Trastuzumab combination with concomitant Locoregional radiotherapy for the treatment of breast cancers with HER2 receptor Overexpression. Cancers 13(19):4790","journal-title":"Cancers"},{"issue":"12","key":"2409_CR22","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","volume":"21","author":"PM Poortmans","year":"2020","unstructured":"Poortmans\u00a0PM, Weltens\u00a0C, Fortpied\u00a0C, Kirkove\u00a0C, Peignaux-Casasnovas\u00a0K, Budach\u00a0V et\u00a0al (2020) Internal mammary and medial supraclavicular lymph node chain irradiation in stage\u00a0I\u2013III breast cancer (EORTC 22922\/10925): 15-year results of a\u00a0randomised, phase\u00a03\u00a0trial. Lancet Oncol 21(12):1602\u20131610","journal-title":"Lancet Oncol"},{"issue":"11","key":"2409_CR23","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby\u00a0SC, Ewertz\u00a0M, McGale\u00a0P, Bennet\u00a0AM, Blom-Goldman\u00a0U, Br\u00f8nnum\u00a0D et\u00a0al (2013) Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer. N\u00a0Engl J Med 368(11):987\u2013998","journal-title":"N Engl J Med"},{"key":"2409_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34057","author":"S Allali","year":"2022","unstructured":"Allali\u00a0S, Carton\u00a0M, Sarrade\u00a0T, Querel\u00a0O, Jacquet\u00a0A, Rivera\u00a0S et\u00a0al (2022) CANTO-RT: skin toxicities evaluation of a\u00a0multicentre large prospective cohort of irradiated patients for early-stage breast cancer. Intl Journal of Cancer. https:\/\/doi.org\/10.1002\/ijc.34057","journal-title":"Intl Journal of Cancer"},{"issue":"4","key":"2409_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.canrad.2021.01.005","volume":"25","author":"P Loap","year":"2021","unstructured":"Loap\u00a0P, Beddok\u00a0A, Cao\u00a0KI, Goudjil\u00a0F, Fourquet\u00a0A, Dendale\u00a0R et\u00a0al (2021) Clinical practice of breast cancer protontherapy: a\u00a0single-centre experience from selection to treatment. Cancer\/Radioth\u00e9rapie 25(4):358\u2013365","journal-title":"Cancer\/Radioth\u00e9rapie."},{"issue":"2","key":"2409_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.radonc.2013.03.028","volume":"107","author":"RB Jimenez","year":"2013","unstructured":"Jimenez\u00a0RB, Goma\u00a0C, Nyamwanda\u00a0J, Kooy\u00a0HM, Halabi\u00a0T, Napolitano\u00a0BN et\u00a0al (2013) Intensity modulated proton therapy for postmastectomy radiation of bilateral implant reconstructed breasts: a\u00a0treatment planning study. Radiother Oncol 107(2):213\u2013217","journal-title":"Radiother Oncol"},{"issue":"2","key":"2409_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.meddos.2011.03.001","volume":"37","author":"S Stanic","year":"2012","unstructured":"Stanic\u00a0S, Mathai\u00a0M, Mayadev\u00a0JS, Do\u00a0LV, Purdy\u00a0JA, Chen\u00a0AM (2012) Addition of a\u00a0third field significantly increases dose to the brachial plexus for patients undergoing tangential whole-breast therapy after lumpectomy. Med Dosim 37(2):127\u2013130","journal-title":"Med Dosim"},{"issue":"18","key":"2409_CR28","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.3390\/cancers15184515","volume":"15","author":"J Baude","year":"2023","unstructured":"Baude\u00a0J, Dendale\u00a0R, Cao\u00a0K, Fourquet\u00a0A, Kirova\u00a0Y (2023) Tolerance and Oncological Outcomes of In-Field Reirradiation for Locally Recurrent Breast Cancer: A\u00a0Long-Term Single-Center Experience. Cancers 15(18):4515","journal-title":"Cancers"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02409-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-025-02409-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02409-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:06:33Z","timestamp":1770195993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-025-02409-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2409"],"URL":"https:\/\/doi.org\/10.1007\/s00066-025-02409-9","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.\u00a0Cheptea, Y.\u00a0Kirova, J.\u00a0Baude, F.\u00a0Laki, A.\u00a0Fourquet, and P.\u00a0Loap declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}